For eight years, the nonprofit Salt Lake Harm Reduction Project has served Salt Lake and its surrounding communities. A main goal is to provide syringe exchanges to reduce the harm caused by drug use, ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback